NAR
2011
12 years 7 months ago
2011
The protein common interface database (ProtCID) is a database that contains clusters of similar homodimeric and heterodimeric interfaces observed in multiple crystal forms (CFs). ...
NAR
2011
12 years 11 months ago
2011
The polyglutamine diseases are caused in part by a gain-of-function mechanism of neuronal toxicity involving protein conformational changes that result in the formation and deposi...
NAR
2011
12 years 11 months ago
2011
The Biological General Repository for Interaction Datasets (BioGRID) is a public database that archives and disseminates genetic and protein interaction data from model organisms ...
NAR
2011
12 years 11 months ago
2011
EcoCyc (http://EcoCyc.org) is a comprehensive model organism database for Escherichia coli K-12 MG1655. From the scientific literature, EcoCyc captures the functions of individual...
NAR
2011
12 years 11 months ago
2011
The REDfly database of Drosophila transcriptional cis-regulatory elements provides the broadest and most comprehensive available resource for experimentally validated cis-regulato...
NAR
2011
12 years 11 months ago
2011
The Hymenoptera Genome Database (HGD) is a comprehensive model organism database that caters to the needs of scientists working on insect species of the order Hymenoptera. This sy...
NAR
2011
12 years 11 months ago
2011
COMBREX (http://combrex.bu.edu) is a project to increase the speed of the functional annotation of new bacterial and archaeal genomes. It consists of a database of functional pred...
NAR
2011
12 years 11 months ago
2011
The Protein–RNA Interface Database (PRIDB) is a comprehensive database of protein–RNA interfaces extracted from complexes in the Protein Data Bank (PDB). It is designed to fac...
NAR
2011
12 years 11 months ago
2011
The Pancreatic Expression database (PED, http:// www.pancreasexpression.org) has established itself as the main repository for pancreatic-derived -omics data. For the past 3 years...
NAR
2011
12 years 11 months ago
2011
The procedure of drug approval is time-consuming, costly and risky. Accidental findings regarding multispecificity of approved drugs led to block-busters in new indication areas. ...